Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filis Kazazi-Hyseni

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Oncologist|August 7, 2010
BevacizumabFilis Kazazi-Hyseni, Jos H Beijnen, Jan H M Schellens
Pharmaceutical Research|May 15, 2014
Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 monthsFilis Kazazi-Hyseni, Mariana Landin, Audrey Lathuile, et al.
Biomaterials|December 28, 2014
Local therapeutic efficacy with reduced systemic side effects by rapamycin-loaded subcapsular microspheresLucas L Falke, Stefan H van Vuuren, Filis Kazazi-Hyseni, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Oncologist|August 7, 2010
BevacizumabFilis Kazazi-Hyseni, Jos H Beijnen, Jan H M Schellens
Pharmaceutical Research|May 15, 2014
Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 monthsFilis Kazazi-Hyseni, Mariana Landin, Audrey Lathuile, et al.
Biomaterials|December 28, 2014
Local therapeutic efficacy with reduced systemic side effects by rapamycin-loaded subcapsular microspheresLucas L Falke, Stefan H van Vuuren, Filis Kazazi-Hyseni, et al.
Pageof 1